Yahoo! JAPAN

2024/5/29 -SMART-C® utilizes fluoroscopy to provide real-time imaging at the point-of-care, setting it apart from traditional X-ray systems that only provide static ...

2023/11/29 -The goal of the KRW 25.5 billion (approx. US$20 million) SMART-C Programme is to promote sustainable maritime transport systems and a sustainable marine ...

2023/9/6 -This innovative C-arm supports a variety of imaging modes, including fluoroscopy and digital radiography (DR). This versatility makes it a multi-functional tool ...

2024/7/8 -The SGLT2 Inhibitor Meta-Analysis Cardio-Renal Trialists' Consortium (SMART-C) comprises completed, randomised, double-blind, placebo-controlled, event-driven ...

2024/4/7 -In brief, SMART-C includes investigators of all large, placebo-controlled, phase 3 outcomes trials of SGLT2i, allowing for sharing of trial data across the ...

2024/4/5 -We conducted a collaborative meta-analysis of SGLT2i trials included in the SGLT2i Meta-Analysis Cardio-Renal Trialists Consortium (SMART-C), restricted to ...

2024/5/29 -X-ray Fluoroscopy Device. The SMART-C® from Turner Imaging Systems is a mini C-arm that provides true portability and flexibility.

2024/4/18 -Meta-analysis of 11 phase 3 trials shows SGLT2 inhibitors reduce cardiovascular event risk by 9% across diverse patient populations.

2024/6/26 -This training is designed to strengthen women's competency and influence within the maritime community, ultimately contributing to a more inclusive and ...

2024/7/8 -SGLT2 inhibitors and GLP-1 receptor agonists both improve cardiovascular and kidney outcomes in patients with type 2 diabetes. We sought to evaluate whether ...